Your browser doesn't support javascript.
loading
Liver dysfunction associated with gold therapy for rheumatoid arthritis.
J Rheumatol ; 10(3): 510-1, 1983 Jun.
Article in En | MEDLINE | ID: mdl-6411922
ABSTRACT
Hepatic toxicity is rarely associated with gold therapy. Three patients with rheumatoid arthritis who developed jaundice during the course of chrysotherapy are described. Jaundice occurred both early and late in the course of therapy. differing grades of severity of dysfunction were encountered. Liver biopsy revealed intrahepatic cholestasis. Significance of jaundice occurring during gold therapy is discussed.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Cholestasis, Intrahepatic / Gold Sodium Thiomalate Type of study: Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: J Rheumatol Year: 1983 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Cholestasis, Intrahepatic / Gold Sodium Thiomalate Type of study: Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: J Rheumatol Year: 1983 Document type: Article